Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 3, 2010, Pages 387-396

  Zarrindast, Mohammad Reza ^a,b,c   Nasehi, Mohammad ^d   Piri, Morteza ^e   Bina, Payvand ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cannabinoids; Hippocampus; Histamine; Hole board; Mice; Pyrilamine; Ranitidine

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; HISTAMINE; HISTAMINERGIC RECEPTOR AFFECTING AGENT; MEPYRAMINE; RANITIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BENZOXAZINES; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HISTAMINE; HISTAMINE ANTAGONISTS; MALE; MICE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; PYRILAMINE; RANITIDINE;

MUS;

EID: 71849118384     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.09.021     Document Type: Article

References (65)

1. Al-Hayani A., and Davies S.N. Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent. Eur J Pharmacol 442 (2002) 47-54
2. Arevalo C., de Miguel R., and Hernandez-Tristan R. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70 (2001) 123-131
3. Arrang J.M., Garbarg M., and Schwartz J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302 (1983) 832-837
4. Ashton C.H. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178 (2001) 101-106
5. Baudry M., Martres M.P., and Schwartz J.C. H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature 253 (1975) 362-364
6. Berrendero F., and Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163 (2002) 111-117
7. Boissier J.R., and Simon P. The exploration reaction in the mouse. Preliminary note. Therapie 17 (1962) 1225-1232
8. Brown R.E., Stevens D.R., and Haas H.L. The physiology of brain histamine. Prog Neurobiol 63 (2001) 637-672
9. Brusco A., Tagliaferro P., Saez T., and Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse (New York, N.Y.) 62 (2008) 944-949
10. Chaperon F., and Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13 (1999) 243-281
11. Davies S.N., Pertwee R.G., and Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42 (2002) 993-1007
12. Degroot A., and Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res 949 (2002) 60-70
13. Dringenberg H.C., De Souza-Silva M.A., Rossmuller J., Huston J.P., and Schwarting R.K. Histamine H1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus. J Neurochem 70 (1998) 1750-1758
14. Frisch C., Hasenohrl R.U., Krauth J., and Huston J.P. Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region. Exp Brain Res 119 (1998) 260-264
15. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 (2006) 10-23
16. Gorelova N., and Reiner P.B. Histamine depolarizes cholinergic septal neurons. J Neurophysiol 75 (1996) 707-714
17. Greene R.W., and Haas H.L. Effects of histamine on dentate granule cells in vitro. Neuroscience 34 (1990) 299-303
18. Haas H.L., and Greene R.W. Effects of histamine on hippocampal pyramidal cells of the rat in vitro. Exp Brain Res 62 (1986) 123-130
19. Haas H.L., and Konnerth A. Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Nature 302 (1983) 432-434
20. Hajos N., and Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43 (2002) 503-510
21. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
22. Haller J., Bakos N., Szirmay M., Ledent C., and Freund T.F. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J NeuroSci 16 (2002) 1395-1398
23. Haller J., Varga B., Ledent C., Barna I., and Freund T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J NeuroSci 19 (2004) 1906-1912
24. Haller J., Varga B., Ledent C., and Freund T.F. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 15 (2004) 299-304
25. Haller J., Matyas F., Soproni K., Varga B., Barsy B., Nemeth B., et al. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J NeuroSci 25 (2007) 2445-2456
26. Hansen W.E., and Bertl S. The inhibition of acetylcholinesterase and pseudocholinesterase by cimetidine. Arzneimittelforschung 33 (1983) 161-163
27. Hegstrand L.R., Kanof P.D., and Greengard P. Histamine-sensitive adenylate cyclase in mammalian brain. Nature 260 (1976) 163-165
28. Imaizumi M., and Onodera K. The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci 53 (1993) 1675-1683
29. Izquierdo I., and Medina J.H. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 63 (1995) 19-32
30. Leurs R., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Ruat M., and Schwartz J.C. Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. J Neurochem 62 (1994) 519-527
31. Maccarrone M., Valverde O., Barbaccia M.L., Castane A., Maldonado R., Ledent C., et al. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J NeuroSci 15 (2002) 1178-1186
32. Mackie K.N.S. Cannabinoid receptors and endocannabinoids: evidence for new players. The AAPS 8 (2006) 298-306
33. Malmberg-Aiello P., Ipponi A., Bartolini A., and Schunack W. Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Behav 71 (2002) 313-318
34. Marco E.M., Perez-Alvarez L., Borcel E., Rubio M., Guaza C., Ambrosio E., et al. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55, 940 in male rats. Behav Pharmacol 15 (2004) 21-27
35. Martin M., Ledent C., Parmentier M., Maldonado R., and Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159 (2002) 379-387
36. Nguyen P.V., Abel T., and Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science (New York, N.Y.) 265 (1994) 1104-1107
37. Patel S., and Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318 (2006) 304-311
38. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., and Hall W. Cannabis use and mental health in young people: cohort study. BMJ 325 (2002) 1195-1198
39. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates. 2nd Ed. (2001), Academic Press
40. Poli E., Coruzzi G., and Bertaccini G. Ranitidine but not famotidine releases acetylcholine from the guinea pig myenteric plexus. Agents Actions 30 (1990) 191-194
41. Privou C., Knoche A., Hasenohrl R.U., and Huston J.P. The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 37 (1998) 1019-1032
42. Rizk A., Curley J., Robertson J., and Raber J. Anxiety and cognition in histamine H3 receptor-/- mice. Eur J NeuroSci 19 (2004) 1992-1996
43. Rodgers R.J., Evans P.M., and Murphy A. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice. Behav Pharmacol 16 (2005) 405-413
44. Rodriguez Echandia E.L., Broitman S.T., and Foscolo M.R. Effect of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats. Pharmacol Biochem Behav 26 (1987) 207-210
45. Roohbakhsh A., Moghaddam A.H., Massoudi R., and Zarrindast M.R. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol 34 (2007) 223-229
46. Rostami P., Hajizadeh-Moghaddam A., and Zarrindast M.R. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours. Physiol Behav 87 (2006) 891-896
47. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 (2007) 1092-1101
48. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22 (2001) 565-572
49. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., and Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 71 (1991) 1-51
50. Sulcova E., Mechoulam R., and Fride E. Biphasic effects of anandamide. Pharmacol Biochem Behav 59 (1998) 347-352
51. Traiffort E., Vizuete M.L., Tardivel-Lacombe J., Souil E., Schwartz J.C., and Ruat M. The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. Biochem Biophys Res Commun 211 (1995) 570-577
52. Tzavara E.T., Wade M., and Nomikos G.G. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J Neurosci 23 (2003) 9374-9384
53. Uriguen L., Perez-Rial S., Ledent C., Palomo T., and Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46 (2004) 966-973
54. Vaccani A., Massi P., Colombo A., Rubino T., and Parolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144 (2005) 1032-1036
55. Valjent E., Mitchell J.M., Besson M.J., Caboche J., and Maldonado R. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135 (2002) 564-578
56. Vinade E.R., Schmidt A.P., Frizzo M.E., Izquierdo I., Elisabetsky E., and Souza D.O. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res 977 (2003) 97-102
57. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295 (1984) 13-25
58. Wilson R.I., and Nicoll R.A. Endocannabinoid signaling in the brain. Science (New York, N.Y.) 296 (2002) 678-682
59. Yamatodani A., Fukuda H., Wada H., Iwaeda T., and Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 344 (1985) 115-123
60. Yanai K., Son L.Z., Endou M., Sakurai E., Nakagawasai O., Tadano T., et al. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 87 (1998) 479-487
61. Yuzurihara M., Ikarashi Y., Ishige A., Sasaki H., Kuribara H., and Maruyama Y. Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice. Pharmacol Biochem Behav 67 (2000) 145-150
62. Zarrindast M.R., Moghadam A.H., Rostami P., and Roohbakhsh A. The effects of histaminergic agents in the central amygdala of rats in the elevated plus-maze test of anxiety. Behav Pharmacol 16 (2005) 643-649
63. Zarrindast M.R., Rostami P., Zarei M., and Roohbakhsh A. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic Clin Pharmacol Toxicol 97 (2005) 276-281
64. Zarrindast M.R., Torabi M., Rostami P., and Fazli-Tabaei S. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 85 (2006) 500-506
65. Zuardi A.W., Shirakawa I., Finkelfarb E., and Karniol I.G. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berl) 76 (1982) 245-250